Insiders · Profile

De Backer Marianne

President and CEO at Vir Biotechnology · Director at ARROWHEAD PHARMACEUTICALS. Filing since 13 Jan 2020. CIK 0001797819

Company
Date
Role
Action
Shares
Amount
Of holding
6 Apr 2026
President and CEO
Sold on a plan
72,559
$664.35K
7.1%
24 Feb 2026
Chief Executive Officer
Sold on a plan
14,762
$140.72K
1.4%
23 Feb 2026
Chief Executive Officer
Sold on a plan
19,039
$141.89K
1.8%
3 Apr 2025
Chief Executive Officer
Sold on a plan
79,712
$474.24K
9.4%
24 Feb 2025
Chief Executive Officer
Sold on a plan
16,122
$152.41K
1.9%
3 Apr 2024
Chief Executive Officer
Sold on a plan
72,995
$690.36K
9.7%
3 Jan 2022
Director
Sold, plan not stated
4,500
$291.18K
20.9%
24 Jun 2021
Director
Sold, plan not stated
5,000
$449.25K
18.9%
8 Oct 2020
Director
Bought
1,000
$50.47K
6.1%
15 Jun 2020
Director
Bought
500
$15.67K
3.1%
15 Apr 2020
Director
Bought
500
$17.70K
3.2%
16 Mar 2020
Director
Bought
500
$11.97K
3.3%
12 Mar 2020
Director
Bought
500
$12.40K
3.4%
11 Mar 2020
Director
Bought
500
$14.30K
3.6%
28 Feb 2020
Director
Bought
500
$17.20K
3.7%
27 Feb 2020
Director
Bought
500
$17.54K
3.8%
13 Jan 2020
Director
Bought
500
$27.48K
4.0%
17 decisions on file.